This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device (NCT06965803)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Cedars-Sina Medical Center — Los Angeles, California

📞 Contact the Study Coordinator

Phone: (310) 967-7434

Email: Mathew.Monterola@cshs.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Diabetes Mellitus

• The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes — Boston, Massachusetts
• Oral Anti Diabetic Agents in the Hospital — Atlanta, Georgia
• Full Plate Living Nutrition Education Program — Madison, Wisconsin
• Evaluation of Arts-Based Storytelling Program in Adolescents With Diabetes — San Francisco, California
• Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes — Cleveland, Ohio
• Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years — Charlestown, Massachusetts

Explore by condition: All Diabetes Mellitus clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.